Randomized phase III study comparing paclitaxel-bleomycin, etoposide, and cisplatin (BEP) to standard BEP in intermediate-prognosis germ-cell cancer: intergroup study EORTC 30983. (Q34136937)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Randomized phase III study comparing paclitaxel-bleomycin, etoposide, and cisplatin (BEP) to standard BEP in intermediate-prognosis germ-cell cancer: intergroup study EORTC 30983. |
scientific article |
Statements
1 reference
Randomized phase III study comparing paclitaxel-bleomycin, etoposide, and cisplatin (BEP) to standard BEP in intermediate-prognosis germ-cell cancer: intergroup study EORTC 30983. (English)
1 reference
Gedske Daugaard
1 reference
Ronald de Wit
1 reference
Iwona Skoneczna
1 reference
Maria De Santis
1 reference
August Garin
1 reference
Nina Aass
1 reference
Alfred J Witjes
1 reference
Peter Albers
1 reference
Jeffery D White
1 reference
José R Germa-Lluch
1 reference
Sandrine Marreaud
1 reference
Laurence Collette
1 reference
23 January 2012
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference